Söndag 11 Maj | 03:52:22 Europe / Stockholm

Prenumeration

2025-05-02 14:40:00

Redeye strengthens its positive view of Formpipe following the Q1 report. Solid ACVs in Q4 2024 and this quarter along with cost cuts, set Formpipe for a year of improving margins.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/